154 related articles for article (PubMed ID: 8820947)
1. The clinical development of paclitaxel: a successful collaboration of academia, industry and the National Cancer Institute.
Donehower RC
Stem Cells; 1996 Jan; 14(1):25-8. PubMed ID: 8820947
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Development of Paclitaxel: A Successful Collaboration of Academia, Industry and the National Cancer Institute.
Donehower RC
Oncologist; 1996; 1(4):240-243. PubMed ID: 10387996
[TBL] [Abstract][Full Text] [Related]
3. Closing Remarks.
Reed E
Oncologist; 1996; 1(4):276-277. PubMed ID: 10388002
[TBL] [Abstract][Full Text] [Related]
4. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
5. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
6. Promising new agents under development by the Division of Cancer Treatment, Diagnosis, and Centers of the National Cancer Institute.
Christian MC; Pluda JM; Ho PT; Arbuck SG; Murgo AJ; Sausville EA
Semin Oncol; 1997 Apr; 24(2):219-40. PubMed ID: 9129691
[TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel-based treatment of lymphoma.
Younes A
Semin Oncol; 1999 Feb; 26(1 Suppl 2):123-8. PubMed ID: 10190794
[TBL] [Abstract][Full Text] [Related]
9. The Antiepileptic Drug Development Program: an example of government-industry collaboration.
White BG
Prog Clin Biol Res; 1985; 197():83-93. PubMed ID: 4070302
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel in the treatment of esophageal cancer.
Weiner LM
Semin Oncol; 1999 Feb; 26(1 Suppl 2):106-8. PubMed ID: 10190790
[TBL] [Abstract][Full Text] [Related]
11. Review and outlook for the role of paclitaxel in urothelial carcinoma.
Vaughn DJ
Semin Oncol; 1999 Feb; 26(1 Suppl 2):117-22. PubMed ID: 10190793
[TBL] [Abstract][Full Text] [Related]
12. Future directions of paclitaxel-based therapy of breast cancer.
Gianni L
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-91-S17-96. PubMed ID: 9374103
[TBL] [Abstract][Full Text] [Related]
13. NIH and NCI support for development of novel therapeutics in gynecologic cancer: a user's guide.
Minig L; Trimble EL; Birrer MJ; Kim KY; Takebe N; Abrams JS
Gynecol Oncol; 2010 Feb; 116(2):177-80. PubMed ID: 19889449
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.
Vogt HG; Martin T; Kolotas C; Schneider L; Strassmann G; Zamboglou N
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
Holmes FA
Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
[TBL] [Abstract][Full Text] [Related]
16. Better infrastructure: industry-academia partnerships--a marriage of convenience?
Abraham E
Crit Care Med; 2009 Jan; 37(1 Suppl):S159-64. PubMed ID: 19104217
[TBL] [Abstract][Full Text] [Related]
17. The current state of adjuvant therapy for breast cancer: focus on paclitaxel.
Hudis CA
Semin Oncol; 1999 Feb; 26(1 Suppl 2):1-5. PubMed ID: 10190778
[TBL] [Abstract][Full Text] [Related]
18. Cancer immunotherapy: breaking the barriers to harvest the crop.
Pardoll D; Allison J
Nat Med; 2004 Sep; 10(9):887-92. PubMed ID: 15340404
[TBL] [Abstract][Full Text] [Related]
19. The evolving role of paclitaxel for patients with carcinoma of unknown primary site.
Greco FA; Hainsworth JD
Semin Oncol; 1999 Feb; 26(1 Suppl 2):129-33. PubMed ID: 10190795
[TBL] [Abstract][Full Text] [Related]
20. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]